#2 First Floor Dukheri Road, Mohra District Ambala 133004
support@curasiamedilabs.com
+91-9316815270, 9499164371, 7988871718
April 17, 2026
The Indian pharmaceutical environment is changing at high rates. To most companies, the conventional way of establishing a huge manufacturing facility, employing hundreds of specialized labor and having elaborate supply chains is a thing of the past. In its place, Third-Party Manufacturing has become the central feature of a more agile, cost-effective and scalable solution.
At Curasia Medilabs, we know that marketing and distribution are the heart of the successful pharma venture. Outsourcing the production process will enable companies to concentrate on their core competency-saving lives by providing life-saving drugs to both patients and healthcare providers.
Contract manufacturing or third-party manufacturing is a manufacturing process in which a firm (the brand owner) contracts another firm (the manufacturer) to manufacture products under its brand name .
This applies in the case of the pharma industry where Curasia Medilabs or its equivalents deal with the whole production process; they source raw materials, package the final product but leave the rights to the brand and marketing to the hiring company. It is a business alliance that fills the gap between a great idea of a product and a commercial drug formulation.
The responsibility is WHO-GMP certifications , labor laws, maintenance of machinery and electricity overheads when you have a factory. These burdens are eliminated in the third-party model. You basically hire the knowledge and resources of an established producer.
The process starts with the selection. It can be tablets, capsules, injectables or syrups and first, you must determine what type of products you want to introduce. At this point, the brand owner gives the required formulations or selects the existing approved list of DCGI (Drug Controller General of India) formulations by the manufacturer.
After the products are complete, a quote is given by the manufacturer. This quote typically consists of:
Some of the papers are required to be by the book. In order to begin third-party production with Curasia Medilabs, you require:
This is where your product obtains its identity. The brand owner gives the design of foils, carton and labels. It is imperative that packaging should be done according to the requirements of the statutes, including the number of the manufacturing license
Once the designs are accepted and the deposit made, the actual manufacturing is commenced. This involves:
Granulation/Mixing: Addition of the API to excipients.
Compression/Filling: Development of the final dose form.
Coating: When necessary (with tablets).
Quality Assurance (QA): Intensive testing to achieve purity and potency specifications of the batch.
Upon clearing of the batch by the lab, the products are packed and sent to the warehouse of the brand owner. It is at this point that the owner will be able to start distributing it via their PCD (Propaganda Cum Distribution) or directly through them.
It costs crores to construct a WHO-GMP-certified unit. You can save on land, machinery and labor by going to a contract manufacturer. This asset-light model will enable you to channel your capital on aggressive marketing and sales growth.
The old players in the manufacturing industry such as Curasia Medilabs are continuously updating their equipment to keep abreast with the competition. By collaborating with us, your brand can enjoy high-end technology and advanced laboratory equipment without necessarily purchasing them.
When your strong point is in sales, why bother to be stuck in ratios of chemicals and factory inspections? Third-party manufacturing would enable you to put 100 per cent of your effort on developing your brand equity and increase of your doctor coverage.
Need 5,000 boxes this month but 20,000 the next? The manufacturers are prepared to deal with the changes in demand much better compared to a small self owned unit.
Although the model is very efficient, a few things should be considered:
Timelines: Production cycles have a duration of 30-45 days on new brands (because of packaging material-acquisition). Solution: Schedule your inventory at least two months.
Quality Consistency: Not all manufacturers maintain the same standards. Resolution: It is always advisable to collaborate with such a company as Curasia Medilabs which has ISO and GMP certifications .
Minimum Order Quantity (MOQ): The majority of manufacturers have a minimum quantity of a product that needs to be ordered to initiate production. Solution: To ensure that you do not overstock, negotiate MOQs according to your original market estimation.
In Curasia Medilabs , we are proud of our state of the art facilities and transparency. Through the management of the complexities of the factory floor, we enable you to create a pharma empire that will be a symbol of trust and excellence.
Query Now!
| How Does Third Party Manufacturing Work in the Pharma Industry? |
|
|
SUMMARY
|
5.0
|
March 20, 2026
March 16, 2026
Leave a Reply